Inhalation of vasoactive intestinal peptide in pulmonary hypertension

H. Leuchte, C. Baezner, R. Baumgartner, C. Neurohr, D. Bevec, G. Bacher, J. Behr (Munich, Germany; Basel, Switzerland)

Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension
Session: Medical treatment of pulmonary hypertension
Session type: Oral Presentation
Number: 3177
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Leuchte, C. Baezner, R. Baumgartner, C. Neurohr, D. Bevec, G. Bacher, J. Behr (Munich, Germany; Basel, Switzerland). Inhalation of vasoactive intestinal peptide in pulmonary hypertension. Eur Respir J 2008; 32: Suppl. 52, 3177

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inhalation of vasoactive intestinal peptide in pulmonary hypertension
Source: Eur Respir J 2008; 32: 1289-1294
Year: 2008



Expression vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets
Source: Eur Respir J 2006; 28: Suppl. 50, 659s
Year: 2006

Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006


Vasoactive intestinal peptide receptors in the airways of smokers with chronic bronchitis
Source: Eur Respir J 2004; 24: 958-963
Year: 2004



N-terminal-pro-brain natriuretic peptide as a haemodynamic marker in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2005; 25: 509-513
Year: 2005



Vasoactive intestinal peptide (VIP) markedly attenuates pulmonary hypertension in fawn-hooded rats
Source: Annual Congress 2005 - Pulmonary hypertension: pathophysiology
Year: 2005


Augmentation of the effects of vasoactive intestinal peptide aerosol on pulmonary hypertension via co-application of a neutral endopeptidase 24.11 inhibitor
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Inhaled vasoactive intestinal peptide exerts immune-regulatory effects in patients with sarcoidosis
Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases
Year: 2009


Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Distribution of vasoactive intestinal peptide( VIP)- and substance P (SP)- containing innervation in bronchi of patients with bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 128s
Year: 2004

Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2006 - Cellular mechanisms of airway disease
Year: 2006


Association of haemodynamic parameters with circulating natriuretic peptides in precapillary pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015

Effects of different pacing modes on vasoactive intestinal peptide levels in pacemaker patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 58s
Year: 2001

Effects of inhaled salbutamol in primary pulmonary hypertension
Source: Eur Respir J 2002; 20: 524-528
Year: 2002



Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertension
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004

Vasoactive and growth factors in pulmonary emphysema
Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD
Year: 2010


Vasoactive intestinal peptide-receptor regulation in monocytes derived from COPD patients
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007


Sildenafil enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 24s
Year: 2002

Brief adrenomedullin inhalation leads to sustained reduction of pulmonary artery pressure
Source: Eur Respir J 2004; 24 : 615-623
Year: 2004



Inhaled vasoactive intestinal peptide (VIP) improves pulmonary gas exchange in acute respiratory distress syndrome (ARDS) - a case report
Source: Eur Respir J 2003; 22: Suppl. 45, 70s
Year: 2003